Akorn to Report First Quarter 2019 Financial Results and Host Conference Call
April 15, 2019 13:56 ET
|
Akorn, Inc.
LAKE FOREST, Ill., April 15, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release before...
Akorn Names Erislandy (Dandy) Dorado-Boladeres as Executive Vice President of Global Quality
March 21, 2019 07:00 ET
|
Akorn, Inc.
LAKE FOREST, Ill., March 21, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX), today announced that Dandy Dorado-Boladeres has been named as Executive Vice President of Global Quality,...
Akorn Comments on Favorable Court Order
March 01, 2019 17:17 ET
|
Akorn, Inc.
LAKE FOREST, Ill., March 01, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX) announced today that the Delaware Court of Chancery has denied a request by Fresenius Kabi AG to bring a fraud claim...
Akorn Provides Fourth Quarter and Full Year 2018 Results
February 28, 2019 07:00 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its financial results for the year ended 2018. ...
Akorn Comments on Fresenius’ Proposed Amended Claims
February 20, 2019 17:25 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX) today announced that it strongly contests Fresenius’ proposed amended claims filed earlier today. Akorn believes these...
Akorn to Report Fourth Quarter and Full Year 2018 Results
February 11, 2019 16:38 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release...
Akorn Announces New Executive and Board Appointments
January 28, 2019 16:30 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), today announced that it has appointed a new executive team member and two new board members. Christopher C. Young...
Akorn Receives FDA Warning Letter
January 09, 2019 07:55 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a warning letter, dated January 4,...
Akorn Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 08, 2019 18:30 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX), today announced that Akorn granted an inducement equity award in accordance with Nasdaq Listing Rule 5635(c)(4)...
Akorn Names Douglas S. Boothe as President and CEO
December 20, 2018 17:05 ET
|
Akorn, Inc.
LAKE FOREST, Ill., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX), today announced that Douglas S. Boothe has been named president and chief executive officer effective January 1,...